56,285 Shares in Globe Life Inc. (NYSE:GL) Purchased by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 56,285 shares of the company's stock, valued at approximately $6,277,000. BI Asset Management Fondsmaeglerselskab A S owned about 0.07% of Globe Life as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Versant Capital Management Inc raised its stake in Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company's stock worth $27,000 after buying an additional 194 shares during the last quarter. Rakuten Securities Inc. bought a new stake in shares of Globe Life in the 4th quarter worth $28,000. Albion Financial Group UT purchased a new stake in Globe Life in the 4th quarter valued at about $28,000. Avalon Trust Co bought a new stake in Globe Life in the fourth quarter worth about $41,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Globe Life by 32.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock valued at $41,000 after purchasing an additional 90 shares during the last quarter. Institutional investors own 81.61% of the company's stock.

Globe Life Price Performance

NYSE GL traded up $1.15 on Wednesday, reaching $122.83. 432,978 shares of the company's stock traded hands, compared to its average volume of 1,023,233. The stock has a market cap of $10.22 billion, a PE ratio of 10.28 and a beta of 0.60. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. Globe Life Inc. has a 12 month low of $71.50 and a 12 month high of $133.76. The stock has a 50-day simple moving average of $124.13 and a 200 day simple moving average of $116.00.

Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. As a group, research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Thursday, April 3rd. This is a boost from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a yield of 0.88%. Globe Life's dividend payout ratio is currently 9.04%.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $122.31, for a total value of $1,345,410.00. Following the transaction, the chief executive officer now owns 18,948 shares in the company, valued at approximately $2,317,529.88. The trade was a 36.73 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 24,890 shares of the firm's stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total value of $3,024,632.80. Following the completion of the sale, the chief executive officer now directly owns 38,973 shares in the company, valued at $4,735,998.96. The trade was a 38.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.51% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GL. BMO Capital Markets began coverage on shares of Globe Life in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 target price for the company. Keefe, Bruyette & Woods boosted their target price on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 12th. Evercore ISI raised Globe Life from an "in-line" rating to an "outperform" rating and raised their price target for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. JPMorgan Chase & Co. boosted their price objective on Globe Life from $136.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Finally, Morgan Stanley decreased their price objective on shares of Globe Life from $126.00 to $117.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Four research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $137.55.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.